Rongce Zhao
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Systemic Treatment Patterns and Clinical Outcomes in Hepatocellular Carcinoma: A Multicenter Real-World Study from China (STAR-HCC).
Journal: JHEP reports : innovation in hepatology
Published: March 21, 2026
Adjuvant systemic therapy versus active surveillance after resection following conversion therapy for hepatocellular carcinoma: a propensity score matched study.
Journal: BMC medicine
Published: March 08, 2026
DLGAP5 regulates malignancy and lenvatinib sensitivity of hepatocellular carcinoma through AKT/mTOR/NF-κB pathway.
Journal: European journal of medical research
Published: August 04, 2025
Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: September 13, 2024
FOLFOX-Based Hepatic Arterial Infusion Chemotherapy with Sequential Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Large Hepatocellular Carcinoma: A Single-Center Retrospective Cohort Study.
Journal: Journal of hepatocellular carcinoma
Published: September 10, 2024
Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: September 05, 2024
Hepatic arterial infusion chemotherapy in combination with lenvatinib and durvalumab versus standard first-line treatment gemcitabine and cisplatin plus durvalumab in advanced intrahepatic cholangiocarcinoma.
Journal: American journal of cancer research
Published: August 28, 2024
Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma.
Journal: Frontiers in immunology
Published: March 08, 2024
Oxaliplatin induces pyroptosis in hepatoma cells and enhances antitumor immunity against hepatocellular carcinoma.
Journal: British journal of cancer
Published: March 03, 2024
A novel benzothiazole derivative induces apoptosis via the mitochondrial intrinsic pathway producing antitumor activity in colorectal cancer.
Journal: Frontiers in pharmacology
Published: April 03, 2023
Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy.
Journal: European journal of medical research
Published: January 13, 2023
Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy.
Journal: Annals of medicine
Published: March 11, 2022
Last Updated: 09/26/2026